Literature DB >> 15655786

Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Aurelia F Porto1, Silvane B Santos, André L Muniz, Vanessa Basilio, Waldyr Rodrigues, Franklin A Neva, Walderez O Dutra, Kenneth J Gollob, Steven Jacobson, Edgar M Carvalho.   

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) infection is associated with an exacerbated type 1 immune response and secretion of high levels of proinflammatory cytokines. In contrast, helminthic infection induces a type 2 immune response. In the present study, the cytokine profile in HTLV-1 carriers coinfected with helminths (Strongyloides stercoralis and/or Schistosoma mansoni) was compared with that in HTLV-1 carriers not coinfected with helminths. Levels of interferon (IFN)- gamma were higher in HTLV-1 carriers not coinfected with helminths than in HTLV-1 carriers coinfected with helminths (P<.05). The overall frequency of IFN- gamma -expressing CD8+ and CD4+ cells was decreased in HTLV-1 carriers coinfected with helminths (P<.05). The percentage of interleukin (IL)-5- and IL-10-expressing T cells in HTLV-1 carriers coinfected with helminths was higher than that in HTLV-1 carriers not coinfected with helminths (P<.05). Moreover, we found that the prevalence of helminthic infection was 7-fold higher in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (P<.05). These data show that helminthic infection decreases activation of type 1 cells, which may influence the clinical outcome of HTLV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655786     DOI: 10.1086/427560

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Helminthic infection and the risk of neurologic disease progression in HTLV-1.

Authors:  Michael A Sundberg; Davi Costa; Gloria Orge; Néviton M Castro; André Muniz; Marshall J Glesby; Edgar M Carvalho
Journal:  J Clin Virol       Date:  2012-01-10       Impact factor: 3.168

2.  Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.

Authors:  Donn M Stewart; Roshan Ramanathan; Siddhartha Mahanty; Daniel P Fedorko; John E Janik; John C Morris
Journal:  Acta Haematol       Date:  2011-04-07       Impact factor: 2.195

3.  Effect of treatment of Strongyloides infection on HTLV-1 expression in a patient with adult T-cell leukemia.

Authors:  Lee Ratner; Christian Grant; Bevin Zimmerman; Joseph Fritz; Gary Weil; Alex Denes; Rama Suresh; Nancy Campbell; Steve Jacobson; Michael Lairmore
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047

4.  Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.

Authors:  Anselmo Souza; Silvane Santos; Lucas P Carvalho; Maria Fernanda R Grassi; Edgar M Carvalho
Journal:  Hum Immunol       Date:  2016-06-06       Impact factor: 2.850

5.  Susceptibility of dendritic cells from individuals with schistosomiasis to infection by Leishmania braziliensis.

Authors:  Diego Mota Lopes; Tarcísio Vila Verde S de Almeida; Robson da Paixão de Souza; Luís Eduardo Viana Ribeiro; Brady Page; Jamille de Souza Fernandes; Edgar M Carvalho; Luciana Santos Cardoso
Journal:  Mol Immunol       Date:  2017-11-29       Impact factor: 4.407

6.  Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.

Authors:  Fernanda Salles; Andrea Bacellar; Mirla Amorim; Glória Orge; Michael Sundberg; Márcia Lima; Silvane Santos; Aurélia Porto; Edgar Carvalho
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-08       Impact factor: 2.184

7.  Recall of intestinal helminthiasis by HIV-infected South Africans and avoidance of possible misinterpretation of egg excretion in worm/HIV co-infection analyses.

Authors:  Vera J Adams; Miles B Markus; Zilungile L Kwitshana; Muhammad A Dhansay; Lize van der Merwe; Gerhard Walzl; John E Fincham
Journal:  BMC Infect Dis       Date:  2006-05-26       Impact factor: 3.090

8.  Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis.

Authors:  Maria de Lourdes Bastos; Silvane B Santos; Anselmo Souza; Brooke Finkmoore; Ohana Bispo; Tasso Barreto; Ingrid Cardoso; Iana Bispo; Flávia Bastos; Daniele Pereira; Lee Riley; Edgar M Carvalho
Journal:  BMC Infect Dis       Date:  2012-08-28       Impact factor: 3.090

9.  Proliferative capacity and cytokine production by cells of HIV-infected and uninfected adults with different helminth infection phenotypes in South Africa.

Authors:  Zilungile L Mkhize-Kwitshana; Musawenkosi Lh Mabaso; Gerhard Walzl
Journal:  BMC Infect Dis       Date:  2014-09-11       Impact factor: 3.090

10.  Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis.

Authors:  Natalia Tiberti; Dora Buonfrate; Carmine Carbone; Geny Piro; Zeno Bisoffi; Chiara Piubelli
Journal:  Parasit Vectors       Date:  2020-10-15       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.